On Jan 21, 2022 SiBionics closed a Series C round and raised $126,000,000 from C&D Emerging Investment, Cedarlake Capital, China Life Investment Holding, CPE, Fortune Capital, JD Investments, Jingming Capital, Lucion, Qianhai Fund of Funds, Riverhead Capital, Source Code Capital, featuring lead investors China Life Investment Holding, CPE.

About the company: SiBionics is located at China, Asia.
“SiBionics is a MedTech startup specialized in the R&D and commercialization of advanced active implantable medical devices and medical artificial intelligence. Our products focus on neuromodulation, health management and medical imaging artificial intelligence. Leveraging our independent R&D and innovation capabilities, we are committed to providing the best patient-centered medical products and service solutions.”

Company website: http://www.sibionics.comen